Glycos Biotechnologies, Inc. Enters Definitive Agreement with Malaysian Bio-XCell for the Set-Up of the Company's Industrial Biochemical Plant and Biotechnology Research and Development Facility

HOUSTON--(BUSINESS WIRE)--Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company’s industrial biochemical plant and biotechnology R&D facility in Malaysia. The Ceremony was held in conjunction with the BioMalaysia 2010 Exhibition and Conference taking place November 1st – 3rd in Kuala Lumpur, Malaysia.